Classical haemorragic disease of the newborn (first week of life) can be effectively prevented by oral or parenteral vitamin K supplementation. Late haemorragic disease of the newborn (2-12 weeks of life) is a rare but severe disease, presenting as intracranial haemorrhage in 50-80% of cases. It occurs in exclusively breastfed infants with inadequate vitamin K prophylaxis, and in infants with malabsorption syndromes. Late haemorragic disease of the newborn can be effectively prevented by a single intramuscular dose at birth. An alternative regimen may be a daily oral vitamin K supplementation for 13 weeks. The American Academy of Pediatrics recommended a single intramuscular dose of vitamin K at birth.
|Translated title of the contribution||Vitamin K deficiency in newborns|
|Number of pages||2|
|Journal||Medico e Bambino|
|Publication status||Published - Nov 30 2003|
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health